Blood Advances · 2024 · 18 citations · 22 references
Life SciencesImmunologyPharmacotherapyClinical ImmunologyImmunopharmacologyImmunotherapyCytotoxic T Lymphocyte ResponsesImmunosuppressionRelapsed DiseaseB-cell Malignancy TherapyChronic Lymphocytic Leukemia TherapyLymphoma RelapseRefractory Chronic Lymphocytic LeukemiaRituximab-based Therapy
22
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 738 citations · Full text
Medicine, Immunology, Oncology +16
Carol Moreno, Richard Greil, Fatih Demırkan et al. · The Lancet Oncology · 2018 · 548 citations
Medicine, Oncology, Pharmacology +13